#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Aplastic anaemia Angiosarcoma non-metastatic Arteriovenous malformation Spinal muscular atrophy Hypertriglyceridaemia Paroxysmal nocturnal haemoglobinuria Mantle cell lymphoma stage II Rhabdomyosarcoma recurrent Osteomyelitis Pancreatic neuroendocrine tumour Post transplant lymphoproliferative disorder Meningitis meningococcal Hidradenitis Retinitis pigmentosa Richter's syndrome More trials…

    Learn about Rare Diseases

    Bronchopulmonary dysplasia – Basic Information Nodal marginal zone B-cell lymphoma – Diagnostics Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Treatment Synovial sarcoma recurrent Proteus syndrome – Trials in Disease Phenylketonuria – Life with Disease Immunodeficiency congenital – Treatment Ornithine transcarbamoylase deficiency – Trials in Disease Alveolar rhabdomyosarcoma – Trials in Disease Glycogen storage disease type V – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    FOSFOMYCIN CALCIUM SODIUM BENZOATE Vemurafenib Rezafungin Acetate Aflibercept Rivaroxaban Gandotinib Florbetaben (18F) Grwd5769 Betaxolol Albaconazole Img-007 Medi0618 Fluvastatin Apraglutide Beclometasone Dipropionate Rapcabtagene Autoleucel Lactic Acid Cx-039776 Travoprost More therapies…

    Learn about Your Condition

    Arrhythmia supraventricular Incisional hernia Dystonic tremor Mucopolysaccharidosis III Venous thrombosis limb Angiosarcoma metastatic Splenic marginal zone lymphoma Pericarditis Latent tuberculosis Myocarditis post infection Macular oedema Duchenne muscular dystrophy Soft tissue sarcoma Toxicity to various agents Lymphocytic lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study of futibatinib combined with tislelizumab, fluorouracil, calcium folinate, and oxaliplatin as first-line treatment for patients with colorectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Futibatinib
    • Tislelizumab
    • Calcium Folinate Pentahydrate
    Germany

  • Study of Remternetug for Prevention of Disease Progression in People at Risk for or With Early Onset Inherited Alzheimer’s Disease

    Recruiting

    4 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • LY3372993
    • N-Methyl-2-(4′-Methylaminophenyl)-6-Hydroxybenzothiazole
    France Germany Italy The Netherlands Spain

  • Study of MK-1084, cetuximab and mFOLFOX6 combination compared to mFOLFOX6 with or without bevacizumab for patients with KRAS G12C-mutant advanced colorectal cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    • K-ras gene mutation
    Investigated Drugs:
    • Mk-1084
    • Calcium Folinate
    • Cetuximab
    Finland France Germany Hungary Italy The Netherlands +3

  • Comparing two forms of mupirocin (gel and ointment) for treating impetigo in children: a study of different dosing schedules

    Recruiting

    3 1 1 1
    Spain

  • Study of ABBV-453 alone or with drug combination for adults with multiple myeloma: evaluation of safety and effectiveness

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone
    • Pomalidomide
    Belgium France Germany Italy Poland Portugal +1

  • Study of mirvetuximab soravtansine dosing schedules for patients with platinum-resistant advanced ovarian, peritoneal, or fallopian tube cancer with high folate receptor expression

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • Prednisolone Acetate
    Belgium France Poland Spain
Previous Page
1 … 159 160 161 162 163 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!